Drug Enforcement D-0159-2023

Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.

Status

Terminated

Classification

Class II

Report Date

January 25, 2023

Termination Date

August 15, 2024

Product Information

Product description
Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054
Product quantity
12192 bottles
Reason for recall
Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.
Recall initiation reason
Initial firm notification
E-Mail
Distribution pattern
Customers in 19 states: CA, FL, GA, IL, KY, LA, MI, MN, MS, NC, NJ, NY, OH, PA, RI, TN, TX, WA, WI; Puerto Rico

Location & Firm

Recalling firm
Ascend Laboratories, LLC
Address
339 Jefferson Rd Ste 101, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0159-2023
Event ID
91385
Recall initiation date
December 28, 2022
Center classification date
January 16, 2023
Code info
Lot # 22140903. Exp. Dec. 2024
More code info